SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 87.21 |
| Enterprise Value ($M) | 58.76 |
| Book Value ($M) | 26.00 |
| Book Value / Share | 4.09 |
| Price / Book | 3.35 |
| NCAV ($M) | 23.95 |
| NCAV / Share | 3.77 |
| Price / NCAV | 3.64 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.49 |
| Return on Assets (ROA) | -0.30 |
| Return on Equity (ROE) | -0.99 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.36 |
| Current Ratio | 2.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 98.21 |
| Assets | 100.26 |
| Liabilities | 74.26 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Gilead Sciences Inc | |||
| 13G/A | Schornstein Alexander | |||
| 13G | Armistice Capital, Llc | 5.58 | -82.30 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,989 | 18,194 | 10.93 | |
| 2,562 | 23,582 | 10.86 | |
| 500 | 13,272 | 3.77 | |
| 1,015 | 12,969 | 7.83 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ARQT – Arcutis Biotherapeutics, Inc. | ARVN – Arvinas, Inc. |
| ARWR – Arrowhead Pharmaceuticals, Inc. | ATHA – Athira Pharma, Inc. |
| ATRA – Atara Biotherapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io